Regulation of Myc driven transcription programs was cited as a consequence of BET inhibition in these tumor models, with BET inhibitors directly silencing MYC gene expression via disruption of BET protein binding at the MYC locus [11,16–18]. The gene discussed is MYC; the disease is neoplasm.